EUVIMEDEUVIMED entdecken
Crossref

Tumor Microenvironment‐Responsive Nanoparticles Amplifying STING Signaling Pathway for Cancer Immunotherapy

Dan Liu, Shuang Liang, Kongshuo Ma, Qian-Fang Meng, Xingang Li, Jian Wei, Mengli Zhou, Kaiqing Yun, Yuanwei Pan, Lang Rao, Xiaoyuan Chen iD, Zhaohui Wang

Advanced Materials · 2024-02 · 36 (6)

DOI: 10.1002/adma.202304845 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 07.12.2023. Verfasst von Dan Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Pek…. Hauptthemen laut MEDLINE: Nanoparticles, Neoplasms. Die Arbeit wurde bisher 108-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences, CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Insufficient activation of the stimulator of interferon genes (STING) signaling pathway and profoundly immunosuppressive microenvironment largely limits the effect of cancer immunotherapy. Herein, tumor microenvironment (TME)‐responsive nanoparticles (PMM NPs) are exploited that simultaneously harness STING and Toll‐like receptor 4 (TLR4) to augment STING activation via TLR4‐mediated nuclear factor‐kappa B signaling pathway stimulation, leading to the increased secretion of type I interferons (i.e., 4.0‐fold enhancement of IFN‐β) and pro‐inflammatory cytokines to promote a specific T cell immune response. Moreover, PMM NPs relieve the immunosuppression of the TME by decreasing the percentage of regulatory T cells, and polarizing M2 macrophages to the M1 type, thus creating an immune‐supportive TME to unleash a cascade adaptive immune response. Combined with an anti‐PD‐1 antibody, synergistic efficacy is achieved in both inflamed colorectal cancer and noninflamed metastatic breast tumor models. Moreover, rechallenging tumor‐free animals with homotypic cells induced complete tumor rejection, indicating the generation of systemic antitumor memory. These TME‐responsive nanoparticles may open a new avenue to achieve the spatiotemporal orchestration of STING activation, providing a promising clinical candidate for next‐generation cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesNeoplasmsAnimalsToll-Like Receptor 4Tumor MicroenvironmentImmunotherapySignal Transduction

Stichwörter der Autor:innen

STING pathwayTLR4 pathwaycancer immunotherapynanoparticlestumor microenvironment

Substanzen

Toll-Like Receptor 4

Autor:innen und Institutionen

  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, China.
  • Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, China.
  • Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, 518132, China.
  • Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
  • Department of Interventional Radiography, Beijing Friendship Hospital, Capital Medical University, Beijing, 10050, China.
  • Department of Diagnostic Radiology, Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119074, Singapore.

ORCID-Profile: Xiaoyuan Chen

Förderung

  • National Natural Science Foundation of China
  • Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
  • CAMS Innovation Fund for Medical Sciences
  • Fundamental Research Funds for the Central Universities
  • National University of Singapore
  • National Medical Research Council
  • Singapore Ministry of Education
  • National Research Foundation

Zitieren

APA

Liu, D., Liang, S., Ma, K., Meng, Q. F., Li, X., Wei, J., Zhou, M., Yun, K., Pan, Y., Rao, L., Chen, X., & Wang, Z. (2024). Tumor Microenvironment‐Responsive Nanoparticles Amplifying STING Signaling Pathway for Cancer Immunotherapy. Advanced Materials, 36(6). https://doi.org/10.1002/adma.202304845

Vancouver

Liu D, Liang S, Ma K, Meng QF, Li X, Wei J, et al. Tumor Microenvironment‐Responsive Nanoparticles Amplifying STING Signaling Pathway for Cancer Immunotherapy. Advanced Materials. 2024;36(6). doi:10.1002/adma.202304845

BibTeX
@article{Liu2024,
  author = {Liu, Dan and Liang, Shuang and Ma, Kongshuo and Meng, Qian-Fang and Li, Xingang and Wei, Jian and Zhou, Mengli and Yun, Kaiqing and Pan, Yuanwei and Rao, Lang and Chen, Xiaoyuan and Wang, Zhaohui},
  title = {Tumor Microenvironment‐Responsive Nanoparticles Amplifying STING Signaling Pathway for Cancer Immunotherapy},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {6},
  doi = {10.1002/adma.202304845}
}
Kostenlos starten →